Noema Pharma
Signal active
Organization
Contact Information
Overview
Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using their novel therapies.
Noema Pharma was founded in 2019 and is based in Basel-Stadt, Switzerland.
About
Industries
Biotechnology, Pharmaceutical, Medical
Founded
2019
Employees
11-50
Headquarters locations
Switzerland, Europe
Social
N/A
Profile Resume
Noema Pharma headquartered in Switzerland, Europe, operates in the Biotechnology, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $4.1B in funding across 24 round(s). With a team of 11-50 employees, Noema Pharma is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Noema Pharma, raised $109.3M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
7
Lead Investors
0
Total Funding Amount
$169.3M
Details
2
Noema Pharma has raised a total of $169.3M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 60.0M | ||
| 2023 | Early Stage Venture | 109.3M |
Investors
Noema Pharma is funded by 19 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Jeito Capital | - | FUNDING ROUND - Jeito Capital | 109.3M |
| Gilde Healthcare | - | FUNDING ROUND - Gilde Healthcare | 109.3M |
| Noema Pharma | - | FUNDING ROUND - Noema Pharma | 109.3M |
| Polaris Partners | - | FUNDING ROUND - Polaris Partners | 109.3M |
Recent Activity
There is no recent news or activity for this profile.